275 related articles for article (PubMed ID: 18691687)
21. Lessons from pregnancy and parturition: uterine leiomyomas result from discordant differentiation and dedifferentiation responses in smooth muscle cells.
Cesen-Cummings K; Walker CL; Davis BJ
Med Hypotheses; 2000 Dec; 55(6):485-90. PubMed ID: 11090295
[TBL] [Abstract][Full Text] [Related]
22. T homozygote and allele of epidermal growth factor receptor 2073 gene polymorphism are associated with higher susceptibility to endometriosis and leiomyomas.
Hsieh YY; Chang CC; Tsai FJ; Lin CC; Tsai CH
Fertil Steril; 2005 Mar; 83(3):796-9. PubMed ID: 15749523
[TBL] [Abstract][Full Text] [Related]
23. Age-specific association of steroid hormone pathway gene polymorphisms with breast cancer risk.
Ralph DA; Zhao LP; Aston CE; Manjeshwar S; Pugh TW; DeFreese DC; Gramling BA; Shimasaki CD; Jupe ER
Cancer; 2007 May; 109(10):1940-8. PubMed ID: 17436274
[TBL] [Abstract][Full Text] [Related]
24. Association between a functional polymorphism in the progesterone receptor gene and panic disorder in women.
Ho HP; Westberg L; Annerbrink K; Olsson M; Melke J; Nilsson S; Baghaei F; Rosmond R; Holm G; Björntorp P; Andersch S; Allgulander C; Eriksson E
Psychoneuroendocrinology; 2004 Oct; 29(9):1138-41. PubMed ID: 15219637
[TBL] [Abstract][Full Text] [Related]
25. [Molecular-genetic determinants of the neoplastic process and state-of-the-art treatment of patients with uterine leiomyoma].
Vikhliaeva EM
Vopr Onkol; 2001; 47(2):200-4. PubMed ID: 11383457
[TBL] [Abstract][Full Text] [Related]
26. Expression profile of the tumorigenic factors associated with tumor size and sex steroid hormone status in uterine leiomyomata.
Wei JJ; Chiriboga L; Mittal K
Fertil Steril; 2005 Aug; 84(2):474-84. PubMed ID: 16084893
[TBL] [Abstract][Full Text] [Related]
27. G-protein-coupled estrogen receptor-30 gene polymorphisms are associated with uterine leiomyoma risk.
Kasap B; Öztürk Turhan N; Edgünlü T; Duran M; Akbaba E; Öner G
Bosn J Basic Med Sci; 2016 Jan; 16(1):39-45. PubMed ID: 26773178
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of clinical parameters and estrogen receptor alpha gene polymorphisms for patients with endometriosis.
Renner SP; Strick R; Oppelt P; Fasching PA; Engel S; Baumann R; Beckmann MW; Strissel PL
Reproduction; 2006 Jan; 131(1):153-61. PubMed ID: 16388018
[TBL] [Abstract][Full Text] [Related]
29. T allele for VEGF-460 gene polymorphism at 5'-untranslated region is associated with higher susceptibility of leiomyoma.
Hsieh YY; Chang CC; Tsai FJ; Lin CC; Tsai CH
Biochem Genet; 2008 Jun; 46(5-6):356-61. PubMed ID: 18256925
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms of CYP17A1, CYP19, and androgen in Brazilian women with uterine leiomyomas.
Rosa FE; Canevari Rde A; Ambrosio EP; Ramos Cirilo PD; Pontes A; Rainho CA; Rogatto SR
Clin Chem Lab Med; 2008; 46(6):814-23. PubMed ID: 18601603
[TBL] [Abstract][Full Text] [Related]
31. No association between estrogen receptor beta polymorphisms and uterine leiomyoma.
Zhai XD; Ye Y; Yang Y; Wang Z; Mo YN
DNA Cell Biol; 2009 Dec; 28(12):633-6. PubMed ID: 19715484
[TBL] [Abstract][Full Text] [Related]
32. Uterine leiomyoma is associated with a polymorphism in the interleukin 1-beta gene.
Pietrowski D; Thewes R; Sator M; Denschlag D; Keck C; Tempfer C
Am J Reprod Immunol; 2009 Aug; 62(2):112-7. PubMed ID: 19614627
[TBL] [Abstract][Full Text] [Related]
33. Microallelotyping defines novel regions of loss of heterozygosity in uterine leiomyomas.
Canevari Rde A; Pontes A; Rogatto SR
Mol Carcinog; 2005 Mar; 42(3):177-82. PubMed ID: 15605361
[TBL] [Abstract][Full Text] [Related]
34. Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study.
Asefi V; Mojtahedi Z; Khademi B; Naeimi S; Ghaderi A
J Laryngol Otol; 2009 Apr; 123(4):444-8. PubMed ID: 18940019
[TBL] [Abstract][Full Text] [Related]
35. Familial multiple cutaneous and uterine leiomyomas associated with papillary renal cell cancer.
Chan I; Wong T; Martinez-Mir A; Christiano AM; McGrath JA
Clin Exp Dermatol; 2005 Jan; 30(1):75-8. PubMed ID: 15663510
[TBL] [Abstract][Full Text] [Related]
36. Growth factors and cytokines in uterine leiomyomas.
Andersen J
Semin Reprod Endocrinol; 1996 Aug; 14(3):269-82. PubMed ID: 8885057
[TBL] [Abstract][Full Text] [Related]
37. Age-dependent association of MDM2 promoter polymorphisms and uterine leiomyoma in South-East Iran: A preliminary report.
Salimi S; Hajizadeh A; Khodamian M; Pejman A; Fazeli K; Yaghmaei M
J Obstet Gynaecol Res; 2015 May; 41(5):729-34. PubMed ID: 25511444
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
39. PROGINS Polymorphism of the Progesterone Receptor Gene and the Susceptibility to Uterine Leiomyomas: A Systematic Review and Meta-Analysis.
da Silva F; Pabalan N; Ekaratcharoenchai N; Serpa Neto A; Christofolini DM; de Oliveira R; Bianco B; Barbosa CP
Genet Test Mol Biomarkers; 2018 May; 22(5):295-301. PubMed ID: 29630404
[TBL] [Abstract][Full Text] [Related]
40. A Role for Progesterone-Regulated sFRP4 Expression in Uterine Leiomyomas.
Delaney MA; Wan YW; Kim GE; Creighton CJ; Taylor MG; Masand R; Park A; Valdes C; Gibbons W; Liu Z; Anderson ML
J Clin Endocrinol Metab; 2017 Sep; 102(9):3316-3326. PubMed ID: 28637297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
